Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment
Author:
Funder
Tianjin Municipal Natural Science Foundation
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference59 articles.
1. Adjuvant treatments for triple-negative breast cancers;Joensuu;Ann. Oncol.,2012
2. STAT3/NF-κB-regulated lentiviral TK/GCV suicide gene therapy for cisplatin-Resistant triple-negative breast cancer;Kuo;Theranostics,2017
3. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment;Pegram;J. Clin. Oncol.,1998
4. Prognostic markers in triple-negative breast cancer;Rakha;Cancer,2007
5. Triple-negative breast cancer: disease entity or title of convenience;Carey;Nat. Rev. Clin. Oncol.,2010
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116;RSC Medicinal Chemistry;2024
2. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action;Успехи химии;2023-10
3. Suppression of epithelial-mesenchymal transition and SIRT1/AKT signaling pathway in breast cancer by montelukast;International Immunopharmacology;2023-06
4. Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position;Journal of Medicinal Chemistry;2022-06-08
5. Long-acting response of COX-2-mediated metastasis inhibition by oxaliplatin-based CP-L-OHP;New Journal of Chemistry;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3